Plasminogen activator inhibitor-1 mRNA is localized in the ciliary epithelium of the rodent eye

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 5, 2000, Pages 1006-1011

  Masos, Tamar ^a   Dan, Jacob A ^a   Miskin, Ruth ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; CILIARY BODY EPITHELIUM; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; FIBRINOLYSIS; MESSENGER RNA SYNTHESIS; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; RAT; TUMOR LOCALIZATION; VAS DEFERENS;

ANIMALS; ANIMALS, NEWBORN; AQUEOUS HUMOR; CILIARY BODY; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; IN SITU HYBRIDIZATION; MICE; MICE, MUTANT STRAINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, WISTAR; RETINAL GANGLION CELLS; RNA, MESSENGER; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0034074982     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Wiman B. Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic disease. Thromb Haemost. 1995;74:71-76.
2. Loskutoff DJ. Regulation of PAI-1 gene expression. Fibrinolysis. 1991;5:197-206.
3. Vassalli J-D, Sappino A-P, Belin D. The plasminogen activator/ plasmin system. J Clin Invest. 1991;88:1067-1072.
4. Rifkin DB. Cross-talk among proteases and matrix in the control of growth factor action. Fibrinolysis & Proteolysis. 1997;11:3-9.
5. Chapman HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol. 1997;9:714-724.
6. Carmeliet P. Insights from gene-inactivation studies of the coagulation and plasminogen. Fibrinolysis & Proteolysis. 1997;11(suppl 2):181-191.
7. Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia. 1991;34:457-462.
8. Schneiderman J, Sawdey MS, Keeton MR, et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA. 1992;89:6998-7002.
9. Bacharach E, Itin A, Keshet E. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci USA. 1992; 89:10686-10690.
10. Simpson AJ, Booth NA, Moore NR, Bennett B. Distribution of plasminogen activator inhibitor (PAI-1) in tissues. J Clin Pathol. 1991;44:139-143.
11. Masos T, Miskin R. mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation. Mol Brain Res. 1997;47:157-169.
12. Hackett SF, Campochiaro PA. Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci. 1993;34:2055-2061.
13. Siren V, Immonen I, Cantell K, Vaheri A. Alpha- and gamma-interferon inhibit plasminogen activator inhibitor-1 gene expression in human retinal pigment epithelial cells. Ophthalmic Res. 1994;26:1-7.
14. Shuman MA, Polansky JR, Merkel C, Alvarado JA. Tissue plasminogen activator in cultured human trabecular meshwork cells: predominance of enzyme over plasminogen activator inhibitor. Invest Ophthalmol Vis Sci. 1988;29:401-405.
15. Tripathi RC, Tripathi BJ, Park JK. Localization of urokinase-type plasminogen activator in human eyes: an immunocytochemical study. Exp Eye Res. 1990;51:545-552.
16. Tripathi RC, Park JK, Tripathi BJ, Millard C. Tissue plasminogen activator in human aqueous humor and its possible therapeutic significance Am J Ophthalmol. 1988;106:719-722.
17. Bernatchez SF, Tabatabay C, Belin D. Urokinase-type plasminogen activator in human aqueous humor. Invest Ophthalmol Vis Sci. 1992;33:2687-2692.
18. Wang Y, Taylor DM, Smalley DM, Cone RE, O'Rourke J. Increased basal levels of free plasminogen activator activity found in human aqueous humor. Invest Ophthalmol Vis Sci. 1994;35: 3561-3566.
19. Smalley DM, Fitzgerald JE, Taylor DM, Cone RE, O'Rourke J. Tissue plasminogen activator activity in human aqueous humor. Invest Ophthalmol Vis Sci. 1994;35:48-53.
20. Pandolfi M, Astrup T. Effect of plasmin on outflow resistance in the primate eye. Proc Soc Exp Biol Med. 1966;121:139-141.
21. Mehra KS, Dube B, Mikuni I, Dube RK. Reduced fibrinolytic activity in aqueous humor of chronic simple glaucoma. Tokai J Exp Clin Med. 1984;9:33-34.
22. O'Rourke J, Lindsay M, Kreutzer D, et al. Evidence of impaired anterior segment fibrinolytic activity in chronic uveitis. Ophthalmic Res. 1982;14:256-264.
23. Miskin R, Axelrod JH, Griep AE, et al. Human and murine urokinase cDNAs linked to the murine αA-crystallin promoter exhibit lens and non-lens expression in transgenic mice. Eur J Biochem. 1990;190:31-38.
24. Pittler SJ, Baehr W. Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase β-subunit gene of the rd mouse Proc Natl Acad Sci USA. 1991;88:8322-8326.
25. Masos T, Miskin R. Localization of urokinase-type plasminogen activator mRNA in the adult mouse brain. Mol Brain Res. 1996; 35:139-148.
26. Miskin R, Abramovitz R. One-phase reverse zymography after denaturing gel electrophoresis: high sensitivity detection of activity of plasminogen activator inhibitor-2 and other protease inhibitors. Fibrinolysis. 1995;9:331-342.
27. Kaufman MH. The Atlas of Mouse Development. San Diego, CA: Academic Press; 1992:294.
28. Vodillo-Ortega F, Gonzalez-Avila G, Chevez P, Abraham CR, Montano M, Selman-Lamoa M. A latent collagenase in human aqueous humor. Invest Ophthalmol Vis Sci. 1989;30:332-335.
29. Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci. 1997; 38:2772-2780.
30. Pasquale LR, Dorman-Pease ME, Lutty GA, Quigley HA, Jampel HD. Immunolocalization of TGF-β1, TGF-β2, and TGF-β3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci. 1993;34:23-30.
31. Jampel HD, Roche N, Stark WJ, Roberts AB. Transforming growth factor-β in human aqueous humor. Curr Eye Res. 1990; 9:963-969.
32. Kolker AE, Hetherington J Jr. In: Kolker AE, Hetherington J Jr, eds. Becker-Shaffer's Diagnosis and Therapy of the Glaucomas. St. Louis, MO: CV Mosby; 1983.
33. Ortego J, Escribano J, Coca-Prados M. Gene expression of proteases and protease inhibitors in the human ciliary epithelium and ODM-2 cells. Exp Eye Res. 1997;65:289-299.
34. Stone J, Itin A, Alon T, et al Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738-4747.
35. Cagliero E, Grant MB, Lorenzi M. Measurement of gene expression in human retinal microvessels by solution hybridization. Invest Ophthalmol Vis Sci. 1991;32:1439-1445.